Evidence map›Paper›PMID 39145716›Full record

ArticleEuropean journal of neurology2024

Functional neurological disorder in Europe: regional differences in education and health policy.

Tereza Serranová, Ilaria Di Vico, Michele Tinazzi, Selma Aybek, Ervina Bilic, Stefanie Binzer, Erlend Bøen, Arnout Bruggeman, Christo Bratanov, Veronica Raquel Alheia Cabreira and 19 more

Abstract read
In one paragraph

Article in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Mark Hallett and the renaissance of functional neurological disorder.Clinical parkinsonism & related disorders · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Tereza SerranováDepartment of Neurology and Center of Clinical Neuroscience, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czechia.ORCID 0000-0001-6525-3971
Ilaria Di VicoDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID 0000-0001-7126-8686
Michele TinazziDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Selma AybekFaculté des Sciences et de Médecine, Université de Fribourg, Fribourg, Switzerland.
Ervina BilicDepartment of Neurology, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
Stefanie BinzerDepartment of Neurology, Kolding Hospital, Kolding, Denmark.
Erlend BøenPsychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Arnout BruggemanDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-0161-9705
Christo BratanovNeurology Department, CHU Grenoble Alpes, Grenoble, France.
Veronica Raquel Alheia CabreiraNeurology Department, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.ORCID 0000-0001-9945-7681
Dawn GolderFND Hope UK, Banbury, UK.
Anna DunalskaPsychiatric Clinic of the Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.
Cristian Falup-PecurariuFaculty of Medicine Brasov, Transilvania University of Brașov, Brașov, Romania.
Beatrice GarcinDepartment of Neurology, Avicenne Hospital, AP-HP, Bobigny, France.ORCID 0000-0001-9109-9904
Jeannette GelauffDepartment of Neurology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Aoife LaffanDepartment of Neurology, St. James's Hospital, Dublin, Ireland.
Simon PodnarDivision of Neurology, Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.ORCID 0000-0003-2541-0172
Isabel PareésMovement Disorders Program, Neurology Department Hospital Ruber Internacional, Madrid, Spain.
Tom PlenderFND Action, Chatham, UK.
Stoyan PopkirovDepartment of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.ORCID 0000-0001-6168-0036
Volodymyr RomanenkoUkrainian Medical Academy, Kyiv, Ukraine.ORCID 0000-0002-0014-9660
Petra SchwingenschuhDepartment of Neurology, Medical University of Graz, Graz, Austria.ORCID 0000-0002-3294-6824
Yury SeliverstovDepartment of Neurology, Ulm University, Ulm, Germany.
Carl SjöströmPrimary Care West Gästrikland, Sandviken, Sweden.
Matej ŠkorvánekDepartment of Neurology, Pavol Jozef Šafárik University, Košice, Slovakia.
Maria StamelouParkinson's Disease and Movement Disorders DepartmentHygeia Hospital, Athens, Greece.
Donatas ZailskasDepartment of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Mark J EdwardsInstitute of Psychiatry, Psychology and NeuroscienceKing's College London, London, UK.
Jon StoneDepartment of Clinical Brain Sciences, The University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.ORCID 0000-0001-9829-8092

Funding

Charles University CooperatioNeuroscienceGeneral University Hospital in Prague MHCZ-DRO-VFN64165
6 · The paper itself

Abstract

backgroundFunctional neurological disorder (FND) is a common cause of neurological disability. Despite recent advances in pathophysiological understanding and treatments, application of this knowledge to clinical practice is variable and limited.

objectiveOur aim was to provide an expert overview of the state of affairs of FND practice across Europe, focusing on education and training, access to specialized care, reimbursement and disability policies, and academic and patient-led representation of people with FND.

methodsWe conducted a survey across Europe, featuring one expert per country. We asked experts to compare training and services for people with FND to those provided to people with multiple sclerosis (MS).

resultsResponses from 25 countries revealed that only five included FND as a mandatory part of neurological training, while teaching about MS was uniformly included. FND was part of final neurology examinations in 3/17 countries, unlike MS that was included in all 17. Seventeen countries reported neurologists with an interest in FND but the estimated mean ratio of FND-interested neurologists to MS neurologists was 1:20. FND coding varied, with psychiatric coding for FND impacting treatment access and disability benefits in the majority of countries. Twenty countries reported services refusing to see FND patients. Eight countries reported an FND special interest group or network; 11 reported patient-led organizations.

conclusionsFND is largely a marginal topic within European neurology training and there is limited access to specialized care and disability benefits for people with FND across Europe. We discuss how this issue can be addressed at an academic, healthcare and patient organization level.

Indexed as

Health PolicyEuropeHealth Services AccessibilityHumansMultiple SclerosisNervous System DiseasesNeurologistsNeurologydisability benefitseducation curriculafunctional neurological disorderhealthcarepatient‐led organization

Identifiers

PMID39145716
PMCPMC11414792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.